The share of US scientific publications in pharmacy among the world's top 10% cited is forecasted to decline from 7.95% in 2024 to 6.8% by 2028. Comparing this to 2023, it can be observed as a consistent downward trend. The year-on-year variation shows a reduction at an average pace, indicating a declining growth rate, with a negative compound annual growth rate (CAGR) projected over the forecast period.

Future trends to watch:

Increased international competition and innovation could further influence the US share.
Policy changes and funding shifts in pharmaceutical research may impact publication quality and citation rates.
Collaborations with emerging markets might offer opportunities to reverse the declining trend.